Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator)

Hua Li1, Gerwald Jogl

  • 1Department of Molecular Biology, Cellular Biology and Biochemistry, Brown University, Providence, Rhode Island 02912, USA.

Insights

TIGAR, a p53-inducible gene, inhibits glycolysis by degrading fructose-2,6-bisphosphate. Structural and biochemical studies reveal its unique histidine phosphatase fold and bisphosphatase activity, offering insights into cellular metabolism regulation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • The p53 tumor suppressor regulates cellular responses to stress, influencing growth inhibition and apoptosis.
  • TIGAR (TP53-induced glycolysis regulator) is a p53-inducible gene that modulates cellular metabolism.
  • TIGAR functions by reducing fructose-2,6-bisphosphate, a key regulator of glycolysis and gluconeogenesis.

Purpose of the Study:

  • To elucidate the structural and biochemical properties of TIGAR from Danio rerio (zebrafish).
  • To understand the enzymatic mechanism and substrate specificity of TIGAR.
  • To compare TIGAR's structure to related phosphatases for functional insights.

Main Methods:

  • X-ray crystallography for structural determination of TIGAR.
  • Biochemical assays to assess enzymatic activity and substrate hydrolysis.
  • Bioinformatic analysis and structural comparisons with homologous proteins.

Main Results:

  • TIGAR exhibits a histidine phosphatase fold with a unique phosphate binding site.
  • Recombinant TIGAR enzymes (human and zebrafish) efficiently hydrolyze fructose-2,6-bisphosphate and fructose-1,6-bisphosphate.
  • The TIGAR active site is open and positively charged, facilitating bisphosphatase activity.

Conclusions:

  • TIGAR possesses a distinct structural and functional profile as a bisphosphatase.
  • Its structure combines features of bacterial phosphatases and bifunctional enzymes, suggesting a specialized role in metabolism.
  • Understanding TIGAR's structure-function relationship provides insights into p53-mediated metabolic control.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...